Topical Everolimus in Patients With Tuberous Sclerosis Complex

NCT02860494 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Pharmaceutical and financial difficulties

Conditions

Facial Angiofibromas

Interventions

DRUG: Everolimus
DRUG: Placebo

Sponsor

Hospices Civils de Lyon